Wednesday December 12, 2018 17:11

Heathcare Press Release : 01 Feb 2018

Semaglutide Demonstrated Significant Reductions in Blood Sugar and Weight Compared with D Results Heathcare—01 Feb 18

Results from the SUSTAIN 7 trial, which investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 mg dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin, have been published in The Lancet